top of page
front page website update01.jpg

Leading 20+ years investments in differentiated innovations for spine surgery

We are a private equity healthtech investment firm with the world's largest portfolio of majority-owned differentiated spine technology companies 

A Growing Problem

Each year, over 266 million people worldwide suffer from degenerative spine disease. At KIC Ventures, we recognize that as people live longer, more active lifestyles, they are increasingly likely to experience disc degeneration and back pain that may require surgery. Traditional spinal fusion performed by spine surgeons limits natural spine movement, often resulting in complications and costly revision surgeries. Many patients seek temporary relief from Interventional Pain Management (IPM) physicians, relying on opioids or spinal cord stimulators—treatments that fail to address the root cause.

Shaping the Future of Spine Care

We are leading the global transition of spine surgery into outpatient centers with our proprietary LESS™ Exposure Spine Surgery philosophy. This approach drives the development of LESS™ Exposure Advanced Spine Technologies (LEAST™), delivering 10x advancements in spine innovations. Through the development, acquisition, and commercialization of pioneering patented technologies, we are transforming spine care for physicians and patients alike.

 

The growing transition to ambulatory surgery centers (ASCs) has fueled demand for our NANISX’s LESS™ invasive spine technologies, which restore natural anatomy, reduce anesthesia risks, and shorten recovery times. This safer, cost-effective approach enables physicians to provide early interventions, while our AxioMed motion-preserving solutions minimize the need for fusion.

A Commitment to Long-Term Value Creation

We deeply value our investors who take a long-term position with us, enabling us to remain nimble and focus on growing value and adoption, with revenues naturally following as a result. Through our private equity model, where we own and operate a portfolio of companies, investors benefit from multiple opportunities for returns as our portfolio companies achieve strategic exits. Beyond financial growth, we offer the chance to invest in transformative solutions that could directly impact your life and the lives of those you care about.

Key Solutions

Focus Areas

At the core of our strategy is an urgent but disciplined approach to selecting niche areas where our strengths lie, aiming to develop best in class solutions with significant market growth potential over the next decade.

Featured Studies

Kingsley R Chin^, Jason A Seale, Carl A Bruce, Warren D Yu, Steven C Anagnost, Vivek P Kushwaha, Roger D Sung, Josue Gabriel, Craig S Meyer, Neil R Crawford, Vito Lore

spine xray

Kingsley R. Chin^, Jason A. Seale, Erik Spayde, William M. Costigan, Nishant Gohel,  Daniel Aloise, Vito Lore.

spine xray

InSpan Slim

Track Record

Business Meeting

200,000+

DEVICES IMPLANTED

100+

GLOBAL PATENTS

35+

US FDA APPROVED DEVICES

80+

INVESTORS: 50 US

30 INTL | 14 COUNTRIES

$85M+

INVESTED CASH: 

$60M+ FOUNDERS | 

$8M+ INVESTORS|

$17M+ PHYSICIANS

$300M

PORTFOLIO REVENUES

90+

RESEARCH PAPERS

10+

ACQUISITIONS & SALE

13+

COUNTRIES TECHNOLOGIES BEEN USED

$20M+

INVESTED DEBT

bottom of page